
Data shows making AstraZeneca vaccine opt-in boosted confidence in NIP
UPDATED 4.38PM | Khairy says 80pct of those who cancelled MySejahtera sign-up re-registered after the brand was removed from NIP.

UPDATED 4.38PM | Khairy says 80pct of those who cancelled MySejahtera sign-up re-registered after the brand was removed from NIP.


UPDATED 26/5 | KINIGUIDE | The company's Covid-19 vaccine has been controversial although its benefits still outweigh its risk.

UPDATED 2.30PM | Online registration includes picking a vaccine centre and date, says the minister.

However, the benefits of the shot continue to outweigh the risks for the majority of people, the MHRA adds.

State minister says those who want that vaccine will have to go to S'gor, KL as it will not be available in S'wak.

Vaccine maker says each batch undergoes over 60 different quality control tests from manufacturing to vaccination.


UPDATED 5.11pm | Special vaccination centres to open in KL and Selangor.

While data backs vaccine's safety, people's anxiety should not be ignored, says Khairy.


He says data shows only 168 cases of thrombosis detected worldwide since March from 21.6 million jabs.

UPDATED 2.25PM | It will be administered to those aged 60 years and older, says health minister.

Health Minister Dr Adham Baba says 268,800 doses of the vaccine arrived last night.

Its health minister says the country has to navigate difficult and occasionally unreasonable demands from drugmakers.

'The issue of safety will have to be straightened out in the European Union.'

Europe's drug regulator finds possible link between AstraZeneca's vaccine and very rare blood clots.

The safest approach is to refer back to the vaccine special committee, says the minister.

Safety is paramount, Khairy Jamaluddin says after the EU findings.

Benefits said to outweigh risks after 169 cases recorded from 34 million doses administered.

European Medicines Agency expected to announce its findings on the company's Covid-19 vaccine tonight.


Available clinical data still points to benefits rather than harms says Dr Adham Baba.

The United States has also removed AstraZeneca from using the facility.